Non-Performing Assets / Total Loans: A classification used by financial institutions that refer to loans that are in jeopardy of default as a potion of total loans made. Calculated as: Non-Perfroming Assets / Gross Loans Made
Arrowhead Pharmaceuticals, Inc. (ARWR) Non-Performing Assets / Total Loans data is not available.
| Income Statement Financials | |
$829.45M |
|
$-1.63M |
|
-- |
|
$829.45M |
|
$731.10M |
|
$98.35M |
|
$-46.81M |
|
$51.53M |
|
$51.53M |
|
$30.11M |
|
$30.11M |
|
$30.11M |
|
$30.11M |
|
$98.35M |
|
$116.48M |
|
133.76M |
|
133.76M |
|
$-0.01 |
|
$-0.01 |
|
| Balance Sheet Financials | |
$950.64M |
|
$382.51M |
|
$434.66M |
|
$1.39B |
|
$195.49M |
|
$214.88M |
|
$686.39M |
|
$881.88M |
|
$503.42M |
|
$496.56M |
|
$503.42M |
|
135.70M |
|
| Cash Flow Statement Financials | |
$179.55M |
|
$-129.29M |
|
$74.01M |
|
$102.69M |
|
$226.55M |
|
$123.86M |
|
$63.37M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.86 |
|
|
Non-Performing Assets / Total Loans |
-- |
-- |
|
0.30 |
|
0.51 |
|
100.00% |
|
11.86% |
|
11.86% |
|
14.04% |
|
6.21% |
|
-0.20% |
|
$156.89M |
|
-- |
|
-- |
|
-- |
|
0.60 |
|
-- |
|
121.55 |
|
3.00 |
|
5.98% |
|
6.06% |
|
2.17% |
|
4.19% |
|
$3.71 |
|
$1.17 |
|
$1.34 |
|